Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.19 USD | +0.97% | -1.70% | -62.77% |
May. 31 | Verve Therapeutics Names Troy Lister Chief Scientific Officer | MT |
May. 31 | Verve Therapeutics, Inc. Announces Executive Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.77% | 432M | |
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |
- Stock Market
- Equities
- VERV Stock
- News Verve Therapeutics, Inc.
- Verve Therapeutics CFO Andrew Ashe Executes Purchase of 76,000 Shares of Common Stock; Shares Jump Premarket